期刊文献+

MiR-29c在大鼠肾间质成纤维细胞中的抗纤维化作用 被引量:5

An anti-fibrosis role of miR-29c in the rat renal interstitial fibroblast cells
在线阅读 下载PDF
导出
摘要 目的:在细胞水平探索miR-29c在肾脏纤维化中的作用。方法:检测TGF-β1对大鼠肾间质成纤维细胞的促纤维化作用及该过程中miR-29c表达的变化。miRanda和高通量测序找出miR-29c的靶基因。通过转染miR-29c mimics(高表达),检测其对胶原I(Col I)表达的影响。结果:TGF-β1能刺激大鼠肾间质成纤维细胞转分化;大鼠肾间质成纤维细胞转分化后miR-29c表达下调;上调miR-29c能抑制TGF-β1的促转分化作用。结论:miR-29c mimics通过有效抑制TGF-β1刺激NRK-49F细胞株Col I表达起到抗纤维化作用,人工合成的miR-29c mimics转染NRK-49F细胞株有效提高miR-29c表达量从而抑制Col I表达,为治疗肾间质纤维化提供了一个新的靶点。 Objective: To explore the role of miR-29c in rat renal fibrosis. Methods:In order to examine transforming growth factor- β1 (TGF- β1) effect on miR-29c and collagen synthesis, rat renal fibroblast cells were treated with TGF-8 1 for different periods of time and concentration. The target gene of miR-29c was forecasted through MiRanda and high- throughput sequencing. Over-expression and down-regulation of miR-29c by miR-29c mimics and inhibitor. Results: TGF-β1 reduced expression of the miR-29c, which targets collagen I expression,and collagen I proteins are increased. Up-regulation of miR-29c could inhibit the effect of TGF-β1 on transdifferentiation, down-regulation of miR-29c can promote the effect of TGF- β1 on transdifferentiation. Conclusion: miR-29c reversal of the profibrotic effects of TGF-β1 on rat renal interstitial fibroblasts, miR-29c may have potential therapeutic for progressive renal fibrosis.
出处 《温州医学院学报》 CAS 2012年第5期413-418,共6页 Journal of Wenzhou Medical College
基金 国家自然科学基金资助项目(30871179/C140405)
关键词 肾脏纤维化 转化生长因子Β1 微RNAS renal fibrosis transforming growth factor-β1 microRNAs
  • 相关文献

参考文献23

  • 1Hornstein E, Mansfield JH, Yekta S, et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb develop- ment[J]. Nature,2005,438(7068):671-674.
  • 2van Rooij E, Sutherland LB, Thatcher JE,et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J]. Proc Natl Acad Sci USA,2008, 105(35): 13027-13032.
  • 3Patrick DM, Montgomery RL, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice[J]. J Clin Invest,2010,120(11):3912-3916.
  • 4Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idio- pathic pulmonary fibrosis[J].Transl Res,2011,157(4): 191 - 199.
  • 5Li J, Zhang Y, Kuruba R, et al. Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells[J]. Mol Pharmacol,2011,80(1):191-200.
  • 6Maurer B, Stanczyk J, Jungel A, et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis[J]. Arthritis Rheum,2010,62(6): 1733-1743.
  • 7Cheng J, Yu H, Deng S,et al. MicroRNA profiling in mid- and late-gestational fetal skin: implication for scarless wound healing[J]. Tohoku J Exp Med,2010,221(3):203-209.
  • 8Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF- beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition[J]. Mol Biol Cell,2011,22(10):1686-1698.
  • 9Wang B, Herman-Edelstein M, Koh P, et al. E-cadherin ex- pression is regulated by miR- 192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta[J]. Diabetes,2010,59(7):1794-1802.
  • 10Ogawa T, Iizuka M, Sekiya Y, et al. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells[J]. Biochem Biophys Res Commun,2010,391 (1):316-321.

二级参考文献27

  • 1Zeisberg M,Strutz F,Muller GA.Role of fibroblast activation in inducing interstitial fibrosis.J Nephrol,2000,13 (Suppl 3):S111-120.
  • 2Jernigan S,Wing D,Schnaper HW,et al.Effects of chronic blockade with soluble TGF-β receptor in rats with overload proteinuria(Abstract).J Am Soc Nephrol,1999,10:573A.
  • 3Kasuga H,Ito Y,Sakamoto S,et al.Effects of anti-TGF-beta type receptor antibody on experimental glomerulonephritis.Kidney Int,2001,60 (5):1745-1755.
  • 4Gupta S,Clarkson MR,Duggan J,et al.Connective tissue growth factor:potential role in glomerulosclerosis and tubulointerstitial fibrosis.Kidney Int,2000,58:1389-1399.
  • 5Guan YF,Breyer MD.Peroxisome proliferator-activated receptors(PPARs):novel therapeutic targets in renal disease.Kidney Int,2001,60:14 -30.
  • 6Zeng F,Fornoni A,Elliot SJ,et al.Upregulation of type Ⅰ collagen by TGF-β in mesangial cells is blocked by PPARγ activation.Am J Physiol.Renal Physiol,2002,282:639-648.
  • 7Baoling G,Daisuke K,Motohide I,et al.Peroxisome proliferatorsactivated receptor-γ ligands inhibit TGF-β1 -induced fibronectin expression in glomerular mesangial cells.Diabetes,2004,53(2):200-208.
  • 8Sawano H,Haneda M,Sugimoto T,et al.15-Deoxy-△12,14-prostaglandin J2 inhibits IL-1β-induced cyclooxygenase-2 expression in mesangial cells.Kidney Int,2002,61 (6):1957-1967.
  • 9Chang PC,Chen TH,Chang CJ,et al.Advanced glycosylation end products induce inducible nitric oxide synthase(iNOS) expression via a p38 MAPK-depeddent pathway.Kidney Int,2004.65(5):1664-1675.
  • 10Panzer U,Schneider A,Guan Y,et al.Effects of different PPARγ-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.Kidney Int,2002,62 (2):455-464.

共引文献67

同被引文献24

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部